FASLG Human (E)-roxithromycin increases expression EXP 6480464 Roxithromycin results in increased expression of FASLG protein CTD PMID:12921874 FASLG Human (R)-adrenaline multiple interactions EXP 6480464 Atenolol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] and carvedilol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] CTD PMID:10728402 FASLG Human (R)-adrenaline increases expression EXP 6480464 Epinephrine results in increased expression of FASLG protein CTD PMID:10728402 FASLG Human (R,R,R)-alpha-tocopherol increases expression ISO Faslg (Rattus norvegicus) 6480464 alpha-Tocopherol results in increased expression of FASLG mRNA CTD PMID:26332274 FASLG Human (S)-naringenin multiple interactions EXP 6480464 [naringenin co-treated with bisphenol A] results in increased expression of FASLG mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of FASLG mRNA CTD PMID:36235125 FASLG Human (S)-naringenin increases expression EXP 6480464 naringenin metabolite results in increased expression of FASLG mRNA CTD PMID:36235125 FASLG Human (S)-nicotine increases expression ISO Faslg (Rattus norvegicus) 6480464 Nicotine results in increased expression of FASLG protein alternative form CTD PMID:18203686 FASLG Human (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of FASLG mRNA and Nicotine results in increased expression of FASLG protein CTD PMID:18247414 more ... FASLG Human (S)-nicotine affects expression ISO Faslg (Rattus norvegicus) 6480464 Nicotine affects the expression of FASLG mRNA CTD PMID:20426880 FASLG Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of FASLG mRNA CTD PMID:22609851 FASLG Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO Faslg (Rattus norvegicus) 6480464 o and p'-DDT results in increased expression of FASLG mRNA CTD PMID:22937105 FASLG Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO Faslg (Rattus norvegicus) 6480464 o and p'-DDT analog results in decreased expression of FASLG mRNA CTD PMID:22937105 FASLG Human 1,2-dichloroethane affects expression ISO Fasl (Mus musculus) 6480464 ethylene dichloride affects the expression of FASL mRNA CTD PMID:28973639 FASLG Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Fasl (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:25406165 FASLG Human 17beta-estradiol multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA more ... CTD PMID:20529085 FASLG Human 17beta-estradiol increases expression ISO Faslg (Rattus norvegicus) 6480464 Estradiol results in increased expression of FASLG mRNA CTD PMID:15545282 FASLG Human 17beta-estradiol multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Estradiol results in increased expression of and results in increased secretion of FASLG protein and Tamoxifen inhibits the reaction [Estradiol results in increased expression of FASLG protein] CTD PMID:15545282 FASLG Human 17beta-estradiol 3-benzoate increases expression ISO Faslg (Rattus norvegicus) 6480464 estradiol 3-benzoate results in increased expression of FASLG mRNA and estradiol 3-benzoate results in increased expression of FASLG protein CTD PMID:24316378 FASLG Human 17beta-estradiol 3-benzoate multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG mRNA] and Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG protein] CTD PMID:24316378 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fasl (Mus musculus) 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA] more ... CTD PMID:15972635 and PMID:16940415 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Faslg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of FASLG mRNA CTD PMID:34747641 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fasl (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FASL mRNA CTD PMID:27913140 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fasl (Mus musculus) 6480464 [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA] which results in increased expression of FASL mRNA more ... CTD PMID:10527913 more ... FASLG Human 2,3,7,8-tetrachlorodibenzodioxine increases response to substance ISO Fasl (Mus musculus) 6480464 FASL protein results in increased susceptibility to Tetrachlorodibenzodioxin CTD PMID:10527913 and PMID:11551431 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Faslg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FASLG mRNA CTD PMID:19520675 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA CTD PMID:11007951 FASLG Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA] CTD PMID:11007951 FASLG Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Fasl (Mus musculus) 6480464 D-JNKI-1 inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of FASL protein] CTD PMID:22427801 FASLG Human 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Fasl (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of FASL protein CTD PMID:22427801 FASLG Human 2,4-D multiple interactions ISO Faslg (Rattus norvegicus) 6480464 lycium barbarum polysaccharide inhibits the reaction [2 and 4-Dichlorophenoxyacetic Acid results in increased expression of FASLG protein] CTD PMID:36214342 FASLG Human 2,4-D increases expression ISO Fasl (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of FASL protein CTD PMID:36214342 FASLG Human 2,4-D multiple interactions ISO Fasl (Mus musculus) 6480464 FAS protein promotes the reaction [2 more ... CTD PMID:36214342 FASLG Human 2,4-D increases expression ISO Faslg (Rattus norvegicus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of FASLG protein CTD PMID:36214342 FASLG Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Fasl (Mus musculus) 6480464 2 more ... CTD PMID:38648751 FASLG Human 2,5-hexanedione increases expression ISO Faslg (Rattus norvegicus) 6480464 2 and 5-hexanedione results in increased expression of FASLG mRNA CTD PMID:22337490 FASLG Human 2,6-dichloroindophenol multiple interactions EXP 6480464 [2 and 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of FASLG mRNA CTD PMID:21034357 FASLG Human 2-naphthylamine decreases expression EXP 6480464 2-Naphthylamine results in decreased expression of FASLG mRNA CTD PMID:18247414 FASLG Human 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO Faslg (Rattus norvegicus) 6480464 Puromycin Aminonucleoside results in increased expression of FASL protein CTD PMID:16152783 FASLG Human 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FASLG protein] CTD PMID:14993511 FASLG Human 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of FASLG mRNA CTD PMID:28070108 FASLG Human 4'-epidoxorubicin increases expression ISO Faslg (Rattus norvegicus) 6480464 Epirubicin results in increased expression of FASLG protein and Epirubicin results in increased expression of FASLG protein modified form CTD PMID:19429229 FASLG Human 4,4'-diaminodiphenylmethane increases expression ISO Fasl (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FASL mRNA CTD PMID:18648102 FASLG Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of FASLG mRNA CTD PMID:33312107 FASLG Human 4,4'-sulfonyldiphenol increases expression ISO Fasl (Mus musculus) 6480464 bisphenol S results in increased expression of FASL mRNA CTD PMID:33297965 FASLG Human 4-hydroperoxycyclophosphamide increases expression EXP 6480464 perfosfamide results in increased expression of FASLG mRNA and perfosfamide results in increased expression of FASLG protein CTD PMID:14760101 FASLG Human 4-nitro-m-cresol increases expression ISO Fasl (Mus musculus) 6480464 4-nitro-3-cresol results in increased expression of FASL mRNA and 4-nitro-3-cresol results in increased expression of FASL protein CTD PMID:29307546 FASLG Human 4-nitro-m-cresol multiple interactions EXP 6480464 CASP3 protein promotes the reaction [4-nitro-3-cresol results in increased expression of FASLG mRNA] more ... CTD PMID:29307546 FASLG Human 4-nitro-m-cresol increases expression EXP 6480464 4-nitro-3-cresol results in increased expression of FASLG mRNA and 4-nitro-3-cresol results in increased expression of FASLG protein CTD PMID:29307546 FASLG Human 4-nonylphenol increases expression ISO Faslg (Rattus norvegicus) 6480464 4-nonylphenol results in increased expression of FASLG mRNA and 4-nonylphenol results in increased expression of FASLG protein CTD PMID:27087316 and PMID:27109770 FASLG Human 5-azacytidine increases response to substance ISO Fasl (Mus musculus) 6480464 Azacitidine results in increased susceptibility to FASLG protein CTD PMID:18829727 FASLG Human 5-azacytidine increases response to substance EXP 6480464 Azacitidine results in increased susceptibility to FASLG protein CTD PMID:18829727 FASLG Human 5-fluorouracil increases response to substance ISO Fasl (Mus musculus) 6480464 FASL results in increased susceptibility to Fluorouracil CTD PMID:11196169 FASLG Human 5-fluorouracil increases expression ISO Fasl (Mus musculus) 6480464 Fluorouracil results in increased expression of FASL CTD PMID:11196169 FASLG Human 8-Br-cAMP multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein CTD PMID:16709600 FASLG Human 9-Methoxycamptothecin increases expression EXP 6480464 9-methoxycamptothecin results in increased expression of FASLG mRNA CTD PMID:23369935 FASLG Human [6]-Shogaol increases expression EXP 6480464 shogaol results in increased expression of FASLG protein CTD PMID:18384088 FASLG Human acetamide increases expression ISO Faslg (Rattus norvegicus) 6480464 acetamide results in increased expression of FASLG mRNA CTD PMID:31881176 FASLG Human acetylsalicylic acid multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Aspirin inhibits the reaction [Azoxymethane results in increased expression of FASLG mRNA] CTD PMID:20043115 FASLG Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with Zidovudine] results in increased expression of FASLG protein more ... CTD PMID:27238871 FASLG Human acrolein multiple interactions ISO Fasl (Mus musculus) 6480464 capsazepine inhibits the reaction [Acrolein results in increased expression of FASL protein] and Glutathione inhibits the reaction [Acrolein results in increased expression of FASL protein] CTD PMID:24376112 FASLG Human acrolein increases expression ISO Fasl (Mus musculus) 6480464 Acrolein results in increased expression of FASL protein CTD PMID:24376112 FASLG Human acrolein increases expression ISO Faslg (Rattus norvegicus) 6480464 Acrolein results in increased expression of FASLG mRNA CTD PMID:27238871 FASLG Human acrolein multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA] more ... CTD PMID:27238871 FASLG Human acrolein increases expression EXP 6480464 Acrolein results in increased expression of FASLG mRNA CTD PMID:27238871 FASLG Human acrylamide increases expression ISO Faslg (Rattus norvegicus) 6480464 Acrylamide results in increased expression of FASLG mRNA CTD PMID:28959563 FASLG Human adenosine increases expression EXP 6480464 Adenosine results in increased expression of FASLG protein CTD PMID:16419169 FASLG Human adenosine multiple interactions ISO Fasl (Mus musculus) 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of FASL mRNA CTD PMID:11992407 FASLG Human aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human aldehydo-D-glucose multiple interactions ISO Fasl (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA CTD PMID:37567420 FASLG Human aldosterone increases expression ISO Faslg (Rattus norvegicus) 6480464 Aldosterone results in increased expression of FASLG protein CTD PMID:19001025 FASLG Human all-trans-acitretin increases expression EXP 6480464 Acitretin results in increased expression of FASLG CTD PMID:18624760 FASLG Human all-trans-retinoic acid multiple interactions EXP 6480464 [Clozapine co-treated with Hydrogen Peroxide co-treated with Tretinoin] results in increased expression of FASLG mRNA CTD PMID:16510162 FASLG Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of FASLG mRNA and Tretinoin results in decreased expression of FASLG protein CTD PMID:16957513 FASLG Human Aloe emodin increases expression EXP 6480464 aloe emodin results in increased expression of FASLG protein CTD PMID:19928967 FASLG Human alpha-naphthoflavone multiple interactions ISO Fasl (Mus musculus) 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA] CTD PMID:16940415 FASLG Human ammonium chloride affects expression ISO Faslg (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of FASLG mRNA CTD PMID:16483693 FASLG Human amphibole asbestos decreases expression EXP 6480464 Asbestos and Amphibole results in decreased expression of FASLG protein CTD PMID:20855422 FASLG Human andrographolide multiple interactions EXP 6480464 [andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein] more ... CTD PMID:24563380 FASLG Human andrographolide increases expression EXP 6480464 andrographolide results in increased expression of FASLG mRNA and andrographolide results in increased expression of FASLG protein CTD PMID:24563380 FASLG Human androst-4-ene-3,17-dione decreases expression ISO Faslg (Rattus norvegicus) 6480464 Androstenedione results in decreased expression of FASLG mRNA CTD PMID:21439382 FASLG Human anthocyanin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of FASLG protein] CTD PMID:28856781 FASLG Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone affects the reaction [temozolomide results in increased expression of FASLG mRNA] more ... CTD PMID:20301194 more ... FASLG Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of FASLG mRNA CTD PMID:24449571 FASLG Human arachidonic acid increases expression EXP 6480464 Arachidonic Acid results in increased expression of FASLG mRNA and Arachidonic Acid results in increased expression of FASLG protein CTD PMID:19720122 FASLG Human arachidonic acid multiple interactions EXP 6480464 1 more ... CTD PMID:19720122 FASLG Human arecoline increases expression ISO Faslg (Rattus norvegicus) 6480464 Arecoline results in increased expression of FASLG protein CTD PMID:33929070 FASLG Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of FASLG mRNA CTD PMID:33212167 FASLG Human aristolochic acid A increases expression ISO Faslg (Rattus norvegicus) 6480464 aristolochic acid I results in increased expression of FASLG protein CTD PMID:35690179 FASLG Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of FASLG mRNA CTD PMID:11134558 and PMID:19962721 FASLG Human arsane increases expression EXP 6480464 Arsenic results in increased expression of FASLG mRNA CTD PMID:27838757 FASLG Human arsane multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of FASLG mRNA CTD PMID:19962721 FASLG Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of FASLG mRNA CTD PMID:11134558 and PMID:19962721 FASLG Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of FASLG mRNA CTD PMID:27838757 FASLG Human arsenic atom multiple interactions EXP 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of FASLG mRNA CTD PMID:19962721 FASLG Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FASLG mRNA CTD PMID:23911876 FASLG Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of FASL protein more ... CTD PMID:12684647 more ... FASLG Human arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of FASLG protein more ... CTD PMID:20416161 more ... FASLG Human arsenous acid affects expression ISO Fasl (Mus musculus) 6480464 Arsenic Trioxide affects the expression of FASL protein CTD PMID:25410152 FASLG Human asbestos decreases expression EXP 6480464 Asbestos results in decreased expression of FASLG CTD PMID:27042963 FASLG Human atenolol multiple interactions EXP 6480464 Atenolol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] CTD PMID:10728402 FASLG Human atorvastatin calcium multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein] CTD PMID:20946910 FASLG Human atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of FASLG protein modified form CTD PMID:15063428 FASLG Human atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of FASLG protein modified form] CTD PMID:15063428 FASLG Human atrazine increases expression ISO Fasl (Mus musculus) 6480464 Atrazine results in increased expression of FASL protein CTD PMID:25259610 FASLG Human atrazine multiple interactions ISO Fasl (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of FASL protein] CTD PMID:25259610 FASLG Human Azoxymethane increases expression ISO Faslg (Rattus norvegicus) 6480464 Azoxymethane results in increased expression of FASLG mRNA CTD PMID:20043115 FASLG Human Azoxymethane multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Aspirin inhibits the reaction [Azoxymethane results in increased expression of FASLG mRNA] CTD PMID:20043115 FASLG Human Azoxymethane multiple interactions ISO Fasl (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of FASLG protein] CTD PMID:20431929 FASLG Human Azoxymethane increases expression ISO Fasl (Mus musculus) 6480464 Azoxymethane results in increased expression of FASLG protein CTD PMID:20431929 FASLG Human bafilomycin A1 multiple interactions ISO Fasl (Mus musculus) 6480464 bafilomycin A1 inhibits the reaction [FASL protein affects the localization of Calcium] CTD PMID:20200208 FASLG Human bafilomycin A1 multiple interactions ISO Faslg (Rattus norvegicus) 6480464 bafilomycin A1 inhibits the reaction [manganese chloride results in increased expression of FASLG protein] CTD PMID:28378122 FASLG Human benazepril multiple interactions ISO Faslg (Rattus norvegicus) 6480464 benazepril inhibits the reaction [Doxorubicin results in increased expression of FASLG protein] more ... CTD PMID:15315341 FASLG Human benzene-1,2,4-triol increases expression EXP 6480464 hydroxyhydroquinone results in increased expression of FASLG protein CTD PMID:23776099 FASLG Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of FASLG mRNA and Benzo(a)pyrene results in increased expression of FASLG protein CTD PMID:16041517 and PMID:18247414 FASLG Human benzo[a]pyrene multiple interactions EXP 6480464 AHR mutant form inhibits the reaction [Benzo(a)pyrene promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]] more ... CTD PMID:16041517 and PMID:22951985 FASLG Human Benzo[k]fluoranthene decreases expression ISO Fasl (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of FASL mRNA CTD PMID:26377693 FASLG Human berberine increases expression EXP 6480464 Berberine results in increased expression of FASLG mRNA and Berberine results in increased expression of FASLG protein CTD PMID:20656010 FASLG Human beta-hexachlorocyclohexane multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of FASLG protein] CTD PMID:19760616 FASLG Human beta-hexachlorocyclohexane increases expression ISO Faslg (Rattus norvegicus) 6480464 beta-hexachlorocyclohexane results in increased expression of FASLG protein CTD PMID:19760616 FASLG Human beta-naphthoflavone multiple interactions EXP 6480464 AHR mutant form inhibits the reaction [beta-Naphthoflavone results in increased activity of [FASLG protein binds to FASLG protein]] and beta-Naphthoflavone results in increased activity of [FASLG protein binds to FASLG protein] CTD PMID:22951985 FASLG Human bezafibrate affects expression EXP 6480464 Bezafibrate affects the expression of FASLG protein modified form CTD PMID:15063428 FASLG Human bifenthrin decreases expression ISO Fasl (Mus musculus) 6480464 bifenthrin results in decreased expression of FASL mRNA CTD PMID:26071804 FASLG Human bis(2-chloroethyl) sulfide multiple interactions EXP 6480464 IL10 protein affects the reaction [Mustard Gas affects the expression of FASLG mRNA] and TNF protein affects the reaction [Mustard Gas affects the expression of FASLG mRNA] CTD PMID:16173061 FASLG Human bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of FASLG mRNA and Mustard Gas results in increased expression of FASLG protein CTD PMID:12482751 and PMID:16173061 FASLG Human bisphenol A increases expression ISO Fasl (Mus musculus) 6480464 bisphenol A results in increased expression of FASL protein CTD PMID:19193734 FASLG Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Quercetin metabolite] results in increased expression of FASLG mRNA more ... CTD PMID:36235125 and PMID:36982678 FASLG Human bisphenol A decreases expression ISO Faslg (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FASLG mRNA CTD PMID:19267065 and PMID:25181051 FASLG Human bisphenol A increases expression ISO Faslg (Rattus norvegicus) 6480464 bisphenol A results in increased expression of FASLG mRNA and bisphenol A results in increased expression of FASLG protein CTD PMID:19267065 more ... FASLG Human bleomycin A2 increases expression ISO Fasl (Mus musculus) 6480464 Bleomycin results in increased expression of FASLG mRNA CTD PMID:11350791 FASLG Human bortezomib multiple interactions EXP 6480464 [Bortezomib co-treated with vorinostat] results in increased expression of FASLG mRNA more ... CTD PMID:17351739 and PMID:20471514 FASLG Human bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of FASLG protein CTD PMID:17351739 FASLG Human bufalin increases expression EXP 6480464 bufalin results in increased expression of FASLG protein CTD PMID:27444971 and PMID:36924737 FASLG Human busulfan decreases expression ISO Fasl (Mus musculus) 6480464 Busulfan results in decreased expression of FASL mRNA CTD PMID:15388331 FASLG Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of FASLG mRNA CTD PMID:33559965 FASLG Human cadmium dichloride increases expression ISO Fasl (Mus musculus) 6480464 Cadmium Chloride results in increased expression of FASL protein CTD PMID:21620867 FASLG Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FASLG mRNA CTD PMID:33129824 FASLG Human cadmium dichloride increases expression ISO Faslg (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of FASLG protein CTD PMID:21819444 FASLG Human cadmium dichloride multiple interactions ISO Faslg (Rattus norvegicus) 6480464 telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] CTD PMID:21819444 FASLG Human cadmium dichloride multiple interactions ISO Fasl (Mus musculus) 6480464 telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] CTD PMID:21620867 FASLG Human Calcimycin affects expression ISO Fasl (Mus musculus) 6480464 Calcimycin affects the expression of FASL protein CTD PMID:25410152 FASLG Human Calcimycin affects expression EXP 6480464 Calcimycin affects the expression of FASLG protein CTD PMID:25410152 FASLG Human calcitriol decreases expression ISO Faslg (Rattus norvegicus) 6480464 Calcitriol results in decreased expression of FASLG protein CTD PMID:17570329 FASLG Human calcium atom multiple interactions ISO Fasl (Mus musculus) 6480464 bafilomycin A1 inhibits the reaction [FASL protein affects the localization of Calcium] more ... CTD PMID:20200208 FASLG Human calcium atom affects localization ISO Fasl (Mus musculus) 6480464 FASL protein affects the localization of Calcium CTD PMID:20200208 FASLG Human calcium(0) multiple interactions ISO Fasl (Mus musculus) 6480464 bafilomycin A1 inhibits the reaction [FASL protein affects the localization of Calcium] more ... CTD PMID:20200208 FASLG Human calcium(0) affects localization ISO Fasl (Mus musculus) 6480464 FASL protein affects the localization of Calcium CTD PMID:20200208 FASLG Human candesartan multiple interactions ISO Faslg (Rattus norvegicus) 6480464 candesartan inhibits the reaction [Daunorubicin results in increased expression of FASLG protein] CTD PMID:16324756 FASLG Human cannabidiol multiple interactions ISO Fasl (Mus musculus) 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of FASL mRNA CTD PMID:32400224 FASLG Human capsaicin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein] more ... CTD PMID:22150557 FASLG Human capsaicin increases expression ISO Faslg (Rattus norvegicus) 6480464 Capsaicin results in increased expression of FASLG protein CTD PMID:22150557 FASLG Human capsazepine multiple interactions ISO Fasl (Mus musculus) 6480464 capsazepine inhibits the reaction [Acrolein results in increased expression of FASL protein] CTD PMID:24376112 FASLG Human carbachol multiple interactions EXP 6480464 [Carbachol results in increased activity of CHRM1 protein] which results in increased expression of FASLG mRNA and [Carbachol results in increased activity of CHRM1 protein] which results in increased expression of FASLG protein CTD PMID:8683117 FASLG Human carbamazepine increases expression ISO Fasl (Mus musculus) 6480464 Carbamazepine results in increased expression of FASL mRNA CTD PMID:22790970 FASLG Human carbon disulfide increases expression ISO Faslg (Rattus norvegicus) 6480464 Carbon Disulfide results in increased expression of FASLG mRNA CTD PMID:17241545 FASLG Human carbon nanotube decreases expression ISO Fasl (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of FASL mRNA CTD PMID:25554681 FASLG Human carvedilol multiple interactions EXP 6480464 carvedilol inhibits the reaction [Epinephrine results in increased expression of FASLG protein] CTD PMID:10728402 FASLG Human casticin increases expression EXP 6480464 casticin results in increased expression of FASLG protein CTD PMID:27862857 FASLG Human casticin decreases expression EXP 6480464 casticin results in decreased expression of FASLG protein CTD PMID:29098808 FASLG Human catechol increases expression EXP 6480464 catechol results in increased expression of FASLG protein CTD PMID:23776099 FASLG Human CCCP multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Testosterone results in increased expression of FASLG mRNA] CTD PMID:24658017 FASLG Human celastrol increases expression EXP 6480464 celastrol results in increased expression of FASLG protein CTD PMID:21466843 FASLG Human celecoxib multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Celecoxib inhibits the reaction [Freund's Adjuvant results in increased expression of FASLG mRNA] CTD PMID:24932515 FASLG Human chloramphenicol decreases expression ISO Fasl (Mus musculus) 6480464 Chloramphenicol results in decreased expression of FASLG CTD PMID:18559535 FASLG Human chloroquine multiple interactions ISO Fasl (Mus musculus) 6480464 Chloroquine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased secretion of FASL protein] CTD PMID:22341560 FASLG Human chlorpyrifos increases expression ISO Fasl (Mus musculus) 6480464 Chlorpyrifos results in increased expression of FASLG mRNA CTD PMID:27737797 FASLG Human cholesterol increases expression ISO Faslg (Rattus norvegicus) 6480464 Cholesterol analog results in increased expression of FASLG protein CTD PMID:19477266 FASLG Human choline multiple interactions ISO Fasl (Mus musculus) 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of FASL protein and PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of FASL protein] CTD PMID:29246445 FASLG Human chrysazin increases expression EXP 6480464 danthron results in increased expression of FASLG protein CTD PMID:21126053 FASLG Human chrysin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of FASLG mRNA] CTD PMID:24932515 FASLG Human cisplatin multiple interactions ISO Fasl (Mus musculus) 6480464 [Cisplatin co-treated with vinorelbine] results in decreased expression of FASL mRNA CTD PMID:21544650 FASLG Human cisplatin increases response to substance ISO Fasl (Mus musculus) 6480464 FASL protein results in increased susceptibility to Cisplatin CTD PMID:9182976 FASLG Human cisplatin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 1 more ... CTD PMID:12684229 and PMID:29216766 FASLG Human cisplatin increases expression ISO Faslg (Rattus norvegicus) 6480464 Cisplatin results in increased expression of FASLG mRNA and Cisplatin results in increased expression of FASLG protein CTD PMID:12684229 and PMID:29216766 FASLG Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of FASLG mRNA and Cisplatin results in increased expression of FASLG protein CTD PMID:16957513 more ... FASLG Human cisplatin multiple interactions EXP 6480464 [andrographolide co-treated with Cisplatin] promotes the reaction [FAS protein binds to FASLG protein] more ... CTD PMID:17574045 more ... FASLG Human clothianidin increases expression ISO Fasl (Mus musculus) 6480464 clothianidin results in increased expression of FASLG mRNA CTD PMID:35264496 FASLG Human clozapine multiple interactions EXP 6480464 [Clozapine analog co-treated with Hydrogen Peroxide] results in increased expression of FASLG mRNA and [Clozapine co-treated with Hydrogen Peroxide co-treated with Tretinoin] results in increased expression of FASLG mRNA CTD PMID:16510162 FASLG Human cobalt atom increases expression ISO Fasl (Mus musculus) 6480464 Cobalt results in increased expression of FASL mRNA CTD PMID:22147119 FASLG Human cobalt atom increases expression EXP 6480464 Cobalt results in increased expression of FASL mRNA CTD PMID:18078969 FASLG Human cobalt atom multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of FASL mRNA CTD PMID:18078969 FASLG Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FASLG mRNA CTD PMID:17553155 FASLG Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FASL mRNA CTD PMID:18078969 FASLG Human coenzyme Q10 multiple interactions ISO Faslg (Rattus norvegicus) 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of FASLG protein] CTD PMID:27087047 FASLG Human coformycin multiple interactions ISO Fasl (Mus musculus) 6480464 [Adenosine co-treated with Coformycin] results in decreased expression of FASL mRNA CTD PMID:11992407 FASLG Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of FASLG mRNA CTD PMID:21765606 FASLG Human copper(II) sulfate multiple interactions EXP 6480464 (4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1 and 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid inhibits the reaction [Copper Sulfate results in increased expression of FASLG mRNA] CTD PMID:21765606 FASLG Human curcumin multiple interactions EXP 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of FASLG protein more ... CTD PMID:17351739 more ... FASLG Human curcumin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [fenpropathrin results in increased expression of FASL mRNA] CTD PMID:38369055 FASLG Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of FASLG mRNA CTD PMID:16101141 FASLG Human curcumin decreases expression ISO Faslg (Rattus norvegicus) 6480464 Curcumin results in decreased expression of FASLG mRNA CTD PMID:10925121 FASLG Human cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FASLG mRNA] CTD PMID:11007951 FASLG Human cycloheximide multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A mRNA and [Cycloheximide co-treated with FASLG protein] results in decreased expression of DNMT3A protein CTD PMID:19833194 FASLG Human cyclophosphamide multiple interactions EXP 6480464 [Cyclophosphamide co-treated with NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt] results in increased expression of FASLG CTD PMID:16166447 FASLG Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of FASLG protein CTD PMID:9247148 FASLG Human cyclosporin A multiple interactions ISO Fasl (Mus musculus) 6480464 Cyclosporine inhibits the reaction [FASLG protein results in increased activity of CAPN1 protein] CTD PMID:23283937 FASLG Human cyclosporin A increases expression ISO Faslg (Rattus norvegicus) 6480464 Cyclosporine results in increased expression of FASLG mRNA CTD PMID:10617104 FASLG Human cyclosporin A multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Cyclosporine inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] and Cyclosporine inhibits the reaction [Doxorubicin results in increased expression of FASLG protein] CTD PMID:15799720 FASLG Human cyclosporin A decreases secretion EXP 6480464 Cyclosporine results in decreased secretion of FASLG protein CTD PMID:11692113 FASLG Human D-glucose increases expression EXP 6480464 Glucose results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human D-glucose multiple interactions ISO Fasl (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA CTD PMID:37567420 FASLG Human daunorubicin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 candesartan inhibits the reaction [Daunorubicin results in increased expression of FASLG protein] CTD PMID:16324756 FASLG Human daunorubicin increases expression ISO Faslg (Rattus norvegicus) 6480464 Daunorubicin results in increased expression of FASLG protein CTD PMID:16324756 FASLG Human DDE multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA] and Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein] CTD PMID:19644561 FASLG Human DDE increases expression ISO Faslg (Rattus norvegicus) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG mRNA and Dichlorodiphenyl Dichloroethylene results in increased expression of FASLG protein CTD PMID:16921742 more ... FASLG Human DDT increases expression ISO Faslg (Rattus norvegicus) 6480464 DDT results in increased expression of FASLG mRNA CTD PMID:29477483 FASLG Human deoxynivalenol increases expression ISO Fasl (Mus musculus) 6480464 deoxynivalenol results in increased expression of FASL mRNA CTD PMID:22968694 FASLG Human dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of FASLG protein CTD PMID:9528991 FASLG Human dexamethasone increases expression ISO Fasl (Mus musculus) 6480464 Dexamethasone results in increased expression of FASL mRNA CTD PMID:12513834 FASLG Human dexamethasone decreases expression ISO Faslg (Rattus norvegicus) 6480464 Dexamethasone results in decreased expression of FASLG mRNA and Dexamethasone results in decreased expression of FASLG protein CTD PMID:11778176 FASLG Human dexamethasone decreases secretion EXP 6480464 Dexamethasone results in decreased secretion of FASLG protein CTD PMID:11692113 FASLG Human diarsenic trioxide affects expression ISO Fasl (Mus musculus) 6480464 Arsenic Trioxide affects the expression of FASL protein CTD PMID:25410152 FASLG Human diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of FASLG protein more ... CTD PMID:20416161 more ... FASLG Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of FASL protein more ... CTD PMID:12684647 more ... FASLG Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FASLG mRNA CTD PMID:23911876 FASLG Human diazinon multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA] CTD PMID:27920530 FASLG Human diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of FASLG mRNA CTD PMID:27920530 FASLG Human dibenziodolium multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased expression of FASL protein] CTD PMID:15799720 FASLG Human dibromoacetic acid increases expression ISO Fasl (Mus musculus) 6480464 dibromoacetic acid results in increased expression of FASL protein CTD PMID:18628252 FASLG Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of FASLG mRNA CTD PMID:37042841 FASLG Human dichlorvos decreases expression ISO Fasl (Mus musculus) 6480464 Dichlorvos results in decreased expression of FASL protein CTD PMID:15369847 FASLG Human diclofenac increases expression ISO Fasl (Mus musculus) 6480464 Diclofenac results in increased expression of FASL mRNA CTD PMID:22285467 FASLG Human diethylstilbestrol increases expression ISO Faslg (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of FASLG protein CTD PMID:12477725 FASLG Human diethylstilbestrol increases expression ISO Fasl (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of FASL mRNA CTD PMID:15545218 and PMID:16510352 FASLG Human diethylstilbestrol multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Diethylstilbestrol results in increased expression of FASLG protein] CTD PMID:12477725 FASLG Human dihydroxyacetone affects expression EXP 6480464 Dihydroxyacetone affects the expression of FASLG mRNA CTD PMID:32506039 FASLG Human Dimethyl phthalate increases expression ISO Faslg (Rattus norvegicus) 6480464 dimethyl phthalate results in increased expression of FASLG mRNA CTD PMID:35598668 FASLG Human dimethyl sulfoxide decreases expression ISO Faslg (Rattus norvegicus) 6480464 Dimethyl Sulfoxide results in decreased expression of FASLG mRNA CTD PMID:10925121 FASLG Human dimethylarsinic acid increases expression ISO Faslg (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of FASLG mRNA CTD PMID:17481689 FASLG Human dimethylarsinic acid decreases expression ISO Fasl (Mus musculus) 6480464 Cacodylic Acid results in decreased expression of FASL mRNA CTD PMID:15345372 FASLG Human dioscin increases expression EXP 6480464 dioscin results in increased expression of FASLG mRNA and dioscin results in increased expression of FASLG protein CTD PMID:22334414 and PMID:29990575 FASLG Human dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:23452621 FASLG Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of FASLG mRNA CTD PMID:23452621 FASLG Human disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of FASLG mRNA CTD PMID:34182011 FASLG Human doxazosin increases expression EXP 6480464 Doxazosin results in increased expression of FASLG mRNA CTD PMID:12771931 FASLG Human doxorubicin multiple interactions EXP 6480464 [FAS protein co-treated with FASLG protein] results in increased susceptibility to Doxorubicin more ... CTD PMID:15763944 more ... FASLG Human doxorubicin increases expression ISO Fasl (Mus musculus) 6480464 Doxorubicin results in increased expression of FASL mRNA CTD PMID:34713381 FASLG Human doxorubicin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 1 more ... CTD PMID:15315341 more ... FASLG Human doxorubicin increases expression ISO Faslg (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of FASL protein more ... CTD PMID:12107157 more ... FASLG Human doxorubicin increases secretion ISO Faslg (Rattus norvegicus) 6480464 Doxorubicin results in increased secretion of FASLG protein CTD PMID:15703961 FASLG Human doxorubicin multiple interactions ISO Fasl (Mus musculus) 6480464 [THBS1 protein alternative form co-treated with Doxorubicin] results in increased expression of FASLG protein and SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of FASL mRNA] CTD PMID:15818399 and PMID:34713381 FASLG Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FASLG mRNA CTD PMID:15763944 and PMID:17088865 FASLG Human EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor decreases expression ISO Fasl (Mus musculus) 6480464 Angiotensin-Converting Enzyme Inhibitors results in decreased expression of FASLG protein CTD PMID:10971519 FASLG Human elemental selenium multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA] CTD PMID:27920530 FASLG Human emodin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased expression of FASLG protein] more ... CTD PMID:27032576 FASLG Human emodin increases expression EXP 6480464 Emodin results in increased expression of FASLG protein CTD PMID:27032576 FASLG Human enalapril decreases expression ISO Faslg (Rattus norvegicus) 6480464 Enalapril results in decreased expression of FASLG mRNA CTD PMID:10925121 FASLG Human esculetin multiple interactions EXP 6480464 [esculetin co-treated with Paclitaxel] results in increased expression of FASLG protein CTD PMID:16051289 FASLG Human ethanol multiple interactions EXP 6480464 Ethanol promotes the reaction [RELA protein binds to FASLG promoter] and Ethanol promotes the reaction [SP1 protein binds to FASLG promoter] CTD PMID:24899502 FASLG Human ethanol increases expression ISO Faslg (Rattus norvegicus) 6480464 Ethanol results in increased expression of FASLG protein CTD PMID:29339218 FASLG Human ethanol multiple interactions ISO Faslg (Rattus norvegicus) 6480464 beta-patchoulene analog inhibits the reaction [Ethanol results in increased expression of FASLG protein] and Lansoprazole inhibits the reaction [Ethanol results in increased expression of FASLG protein] CTD PMID:29339218 FASLG Human etoposide multiple interactions EXP 6480464 [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter] more ... CTD PMID:10811113 FASLG Human etoposide increases expression ISO Fasl (Mus musculus) 6480464 Etoposide results in increased expression of FASL mRNA CTD PMID:12513834 FASLG Human etoposide increases activity EXP 6480464 Etoposide results in increased activity of FASLG promoter CTD PMID:10811113 FASLG Human Evodiamine increases expression EXP 6480464 evodiamine results in increased expression of FASLG protein CTD PMID:20005289 FASLG Human Evodiamine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [evodiamine results in increased expression of FASLG protein] more ... CTD PMID:20005289 FASLG Human fenpropathrin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [fenpropathrin results in increased expression of FASL mRNA] CTD PMID:38369055 FASLG Human fenpropathrin increases expression ISO Faslg (Rattus norvegicus) 6480464 fenpropathrin results in increased expression of FASL mRNA CTD PMID:38369055 FASLG Human fenvalerate increases expression ISO Faslg (Rattus norvegicus) 6480464 fenvalerate results in increased expression of FASLG mRNA CTD PMID:30307764 FASLG Human fisetin multiple interactions EXP 6480464 [Cisplatin co-treated with fisetin] results in increased expression of FASLG protein CTD PMID:21216935 FASLG Human fisetin increases expression EXP 6480464 fisetin results in increased expression of FASLG protein CTD PMID:21216935 FASLG Human flavanone increases expression EXP 6480464 flavanone results in increased expression of FASLG mRNA CTD PMID:22056764 FASLG Human flavonoids multiple interactions ISO Fasl (Mus musculus) 6480464 Flavonoids inhibits the reaction [Carbon Tetrachloride results in increased expression of FASL mRNA] CTD PMID:23279844 FASLG Human flavonoids increases expression ISO Faslg (Rattus norvegicus) 6480464 Flavonoids results in increased expression of FASLG mRNA CTD PMID:18035473 FASLG Human flucloxacillin multiple interactions ISO Fasl (Mus musculus) 6480464 [Floxacillin co-treated with CpG ODN 1826] results in decreased expression of FASL protein and FASL protein affects the reaction [[Floxacillin co-treated with CpG ODN 1826] results in increased expression of GPT protein] CTD PMID:30993380 FASLG Human flutamide decreases expression ISO Faslg (Rattus norvegicus) 6480464 Flutamide results in decreased expression of FASLG protein CTD PMID:20850791 FASLG Human flutamide increases expression ISO Faslg (Rattus norvegicus) 6480464 Flutamide results in increased expression of FASLG mRNA CTD PMID:16166221 FASLG Human flutamide multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Flutamide inhibits the reaction [Testosterone results in increased expression of FASLG mRNA] CTD PMID:24658017 FASLG Human formaldehyde increases expression ISO Faslg (Rattus norvegicus) 6480464 Formaldehyde results in increased expression of FASLG mRNA CTD PMID:12679049 FASLG Human fructose increases expression EXP 6480464 Fructose results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human fructose multiple interactions ISO Fasl (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA CTD PMID:37567420 FASLG Human fulvestrant decreases expression EXP 6480464 fulvestrant results in decreased expression of FASLG mRNA CTD PMID:20145137 FASLG Human fulvestrant decreases methylation EXP 6480464 Fulvestrant results in decreased methylation of FASLG gene CTD PMID:31601247 FASLG Human fulvestrant increases expression EXP 6480464 [fulvestrant results in increased expression of TGFB1 protein] which results in increased expression of FASLG mRNA CTD PMID:20145137 FASLG Human furan increases expression ISO Faslg (Rattus norvegicus) 6480464 furan results in increased expression of FASLG mRNA CTD PMID:22079235 FASLG Human furosemide affects expression ISO Faslg (Rattus norvegicus) 6480464 Furosemide affects the expression of FASLG mRNA CTD PMID:17497460 FASLG Human Fusarenone X decreases expression ISO Fasl (Mus musculus) 6480464 fusarenon-X results in decreased expression of FASL mRNA CTD PMID:24983900 FASLG Human gallic acid increases expression EXP 6480464 Gallic Acid results in increased expression of FASLG protein CTD PMID:22245431 FASLG Human gamma-hexachlorocyclohexane increases expression ISO Faslg (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of FASLG protein CTD PMID:19038305 FASLG Human gefitinib increases response to substance EXP 6480464 Gefitinib results in increased susceptibility to FASLG protein CTD PMID:31168030 FASLG Human gefitinib multiple interactions EXP 6480464 benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Gefitinib results in increased susceptibility to FASLG protein] CTD PMID:31168030 FASLG Human Geniposide pentaacetate increases expression ISO Faslg (Rattus norvegicus) 6480464 pentaacetyl geniposide results in increased expression of FASLG protein CTD PMID:17651887 FASLG Human Geniposide pentaacetate multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of FASLG protein] CTD PMID:17651887 FASLG Human genistein increases expression EXP 6480464 Genistein results in increased expression of FASLG protein CTD PMID:24299158 FASLG Human genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA] CTD PMID:23452621 FASLG Human glucose increases expression EXP 6480464 Glucose results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human glucose multiple interactions ISO Fasl (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA CTD PMID:37567420 FASLG Human glutathione decreases abundance EXP 6480464 FASL protein results in decreased abundance of Glutathione CTD PMID:17724027 FASLG Human glutathione multiple interactions ISO Fasl (Mus musculus) 6480464 Glutathione inhibits the reaction [Acrolein results in increased expression of FASL protein] CTD PMID:24376112 FASLG Human glutathione multiple interactions EXP 6480464 verlukast promotes the reaction [FASL protein results in decreased abundance of Glutathione] CTD PMID:17724027 FASLG Human glycidol increases expression ISO Faslg (Rattus norvegicus) 6480464 glycidol results in increased expression of FASLG mRNA CTD PMID:24915197 FASLG Human glyphosate multiple interactions ISO Fasl (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA CTD PMID:37567420 FASLG Human hexachlorobenzene increases expression ISO Faslg (Rattus norvegicus) 6480464 Hexachlorobenzene results in increased expression of FASLG protein CTD PMID:21787832 FASLG Human hydralazine multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]] more ... CTD PMID:27238871 FASLG Human hydralazine multiple interactions EXP 6480464 Hydralazine inhibits the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]] more ... CTD PMID:27238871 FASLG Human hydrogen peroxide increases chemical synthesis EXP 6480464 FASL protein results in increased chemical synthesis of Hydrogen Peroxide CTD PMID:17724027 FASLG Human hydrogen peroxide increases expression ISO Fasl (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of FASL mRNA and Hydrogen Peroxide results in increased expression of FASL protein CTD PMID:9657385 FASLG Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of FASLG mRNA CTD PMID:21347231 FASLG Human hydrogen peroxide increases expression ISO Faslg (Rattus norvegicus) 6480464 Hydrogen Peroxide results in increased expression of FASLG protein CTD PMID:15799720 FASLG Human hydrogen peroxide multiple interactions ISO Faslg (Rattus norvegicus) 6480464 1 more ... CTD PMID:15799720 FASLG Human hydrogen peroxide multiple interactions EXP 6480464 [Clozapine analog co-treated with Hydrogen Peroxide] results in increased expression of FASLG mRNA more ... CTD PMID:16510162 and PMID:17724027 FASLG Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of FASLG protein CTD PMID:23776099 FASLG Human hydroquinone O-beta-D-glucopyranoside decreases expression EXP 6480464 Arbutin results in decreased expression of FASLG mRNA CTD PMID:17103032 FASLG Human hydroxyurea increases expression ISO Fasl (Mus musculus) 6480464 Hydroxyurea results in increased expression of FASL mRNA and Hydroxyurea results in increased expression of FASL protein CTD PMID:16356682 and PMID:26399158 FASLG Human hyperforin increases expression EXP 6480464 hyperforin results in increased expression of FASLG protein CTD PMID:32485087 FASLG Human idelalisib multiple interactions EXP 6480464 [FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein more ... CTD PMID:31445927 FASLG Human ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of FASL CTD PMID:16453328 FASLG Human inosine increases expression EXP 6480464 Inosine results in increased expression of FASLG protein CTD PMID:16419169 FASLG Human ionomycin multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA more ... CTD PMID:20529085 FASLG Human irinotecan increases expression ISO Fasl (Mus musculus) 6480464 Irinotecan results in increased expression of FASL protein CTD PMID:21475811 FASLG Human irinotecan multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with Irinotecan] results in increased expression of FASLG CTD PMID:15897249 FASLG Human isoflurane decreases expression ISO Faslg (Rattus norvegicus) 6480464 Isoflurane results in decreased expression of FASLG mRNA CTD PMID:16978161 FASLG Human isoprenaline increases expression ISO Faslg (Rattus norvegicus) 6480464 Isoproterenol results in increased expression of FASLG protein CTD PMID:19001025 FASLG Human L-methionine multiple interactions ISO Fasl (Mus musculus) 6480464 Methionine inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA] CTD PMID:19739265 FASLG Human lansoprazole multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Lansoprazole inhibits the reaction [Ethanol results in increased expression of FASLG protein] CTD PMID:29339218 FASLG Human lenalidomide multiple interactions ISO Fasl (Mus musculus) 6480464 lenalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] CTD PMID:16510725 FASLG Human linsidomine multiple interactions EXP 6480464 [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter] and [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] CTD PMID:10811113 FASLG Human lipopolysaccharide multiple interactions EXP 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FASLG mRNA CTD PMID:22777745 FASLG Human lipopolysaccharide increases expression ISO Faslg (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of FASLG protein CTD PMID:31486215 FASLG Human lipopolysaccharide multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Honghua extract and Carthamus tinctorius inhibits the reaction [Lipopolysaccharides results in increased expression of FASLG protein] CTD PMID:31486215 FASLG Human lipopolysaccharide increases expression ISO Fasl (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of FASL mRNA and Lipopolysaccharides results in increased expression of FASLG mRNA CTD PMID:12057914 and PMID:9657385 FASLG Human losartan decreases expression ISO Faslg (Rattus norvegicus) 6480464 Losartan results in decreased expression of FASLG mRNA CTD PMID:10925121 FASLG Human lovastatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] CTD PMID:17088865 FASLG Human lupulone increases expression EXP 6480464 lupulon results in increased expression of FASLG protein CTD PMID:17434926 FASLG Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased expression of FASLG protein] CTD PMID:27032576 FASLG Human lycopene decreases expression EXP 6480464 lycopene results in decreased expression of FASLG mRNA CTD PMID:16886892 FASLG Human magnesium oxide multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA] CTD PMID:27920530 FASLG Human manganese(II) chloride increases expression ISO Faslg (Rattus norvegicus) 6480464 manganese chloride results in increased expression of FASLG protein CTD PMID:21704098 and PMID:28378122 FASLG Human manganese(II) chloride multiple interactions ISO Faslg (Rattus norvegicus) 6480464 bafilomycin A1 inhibits the reaction [manganese chloride results in increased expression of FASLG protein] more ... CTD PMID:28378122 FASLG Human manumycin A multiple interactions ISO Fasl (Mus musculus) 6480464 manumycin inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA] CTD PMID:19739265 FASLG Human masoprocol multiple interactions ISO Fasl (Mus musculus) 6480464 Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP3 protein] and Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein] CTD PMID:10203695 FASLG Human masoprocol multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of FASLG protein] CTD PMID:17651887 FASLG Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein CTD PMID:16709600 FASLG Human melatonin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Melatonin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of FASLG protein] CTD PMID:14993511 FASLG Human melatonin multiple interactions ISO Fasl (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of FASL protein] CTD PMID:25259610 FASLG Human methamphetamine increases expression ISO Faslg (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of FASLG mRNA and Methamphetamine results in increased expression of FASLG protein CTD PMID:15644446 FASLG Human methotrexate multiple interactions ISO Faslg (Rattus norvegicus) 6480464 vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein] CTD PMID:29216766 FASLG Human methotrexate increases expression ISO Faslg (Rattus norvegicus) 6480464 Methotrexate results in increased expression of FASLG protein CTD PMID:29216766 FASLG Human methoxychlor increases expression ISO Faslg (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of FASLG protein CTD PMID:20227399 FASLG Human methylarsonic acid increases expression ISO Faslg (Rattus norvegicus) 6480464 monomethylarsonic acid results in increased expression of FASLG mRNA CTD PMID:17481689 FASLG Human mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]] CTD PMID:12645856 FASLG Human mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of FASLG mRNA CTD PMID:16009178 FASLG Human mitogen increases expression EXP 6480464 Mitogens results in increased expression of FASLG protein CTD PMID:15895164 FASLG Human mitomycin C increases expression EXP 6480464 Mitomycin results in increased expression of FASLG more ... CTD PMID:16019139 more ... FASLG Human Mitotane increases expression ISO Faslg (Rattus norvegicus) 6480464 Mitotane results in increased expression of FASLG mRNA CTD PMID:23485034 FASLG Human MK 571 multiple interactions EXP 6480464 verlukast promotes the reaction [FASL protein results in decreased abundance of Glutathione] CTD PMID:17724027 FASLG Human mono(2-ethylhexyl) phthalate affects response to substance ISO Fasl (Mus musculus) 6480464 FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate and FASL protein modified form affects the susceptibility to mono-(2-ethylhexyl)phthalate CTD PMID:12490136 and PMID:20100735 FASLG Human mono(2-ethylhexyl) phthalate multiple interactions ISO Fasl (Mus musculus) 6480464 [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein more ... CTD PMID:12490136 and PMID:20100735 FASLG Human monocrotaline multiple interactions ISO Fasl (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA CTD PMID:21224054 FASLG Human monosodium L-glutamate multiple interactions ISO Fasl (Mus musculus) 6480464 SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of FASL mRNA] CTD PMID:16782274 FASLG Human monosodium L-glutamate increases expression ISO Fasl (Mus musculus) 6480464 Sodium Glutamate results in increased expression of FASL mRNA CTD PMID:16782274 FASLG Human morin increases expression EXP 6480464 morin results in increased expression of FASLG mRNA CTD PMID:28689916 FASLG Human morphine multiple interactions ISO Fasl (Mus musculus) 6480464 [FAS protein binds to FASL protein] affects the reaction [Morphine results in increased expression of IL4 protein] CTD PMID:16210602 FASLG Human morphine increases expression ISO Fasl (Mus musculus) 6480464 Morphine results in increased expression of FASL mRNA CTD PMID:16210602 FASLG Human Myrtucommulone A increases expression ISO Fasl (Mus musculus) 6480464 myrtucommulone A results in increased expression of FASL mRNA CTD PMID:26032814 FASLG Human N-acetyl-L-cysteine multiple interactions EXP 6480464 [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of FASLG mRNA more ... CTD PMID:17574045 more ... FASLG Human N-acetyl-L-cysteine increases expression ISO Faslg (Rattus norvegicus) 6480464 Acetylcysteine results in increased expression of FASLG mRNA CTD PMID:26332274 FASLG Human N-acetyl-L-cysteine multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein] more ... CTD PMID:19644561 more ... FASLG Human N-acetyl-L-cysteine multiple interactions ISO Fasl (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Azoxymethane results in increased expression of FASLG protein] and Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] CTD PMID:11864783 and PMID:20431929 FASLG Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [evodiamine results in increased expression of FASLG protein] CTD PMID:20005289 FASLG Human N-methyl-N'-nitro-N-nitrosoguanidine decreases expression EXP 6480464 Methylnitronitrosoguanidine results in decreased expression of FASLG protein CTD PMID:24821435 FASLG Human N-nitrosodiethylamine decreases expression ISO Faslg (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of FASL mRNA CTD PMID:19427195 FASLG Human N-nitrosodiethylamine multiple interactions ISO Faslg (Rattus norvegicus) 6480464 thiosalicylic acid inhibits the reaction [Diethylnitrosamine results in decreased expression of FASL mRNA] CTD PMID:19427195 FASLG Human NADP zwitterion multiple interactions ISO Fasl (Mus musculus) 6480464 CD38 gene mutant form inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]] more ... CTD PMID:20200208 FASLG Human NADP(+) multiple interactions ISO Fasl (Mus musculus) 6480464 CD38 gene mutant form inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]] more ... CTD PMID:20200208 FASLG Human naproxen multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein] and Naproxen inhibits the reaction [Capsaicin results in increased expression of FASLG protein] CTD PMID:22150557 FASLG Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of FASLG mRNA CTD PMID:24768652 FASLG Human nicotinamide multiple interactions ISO Fasl (Mus musculus) 6480464 CD38 gene mutant form promotes the reaction [Niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]] and Niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]] CTD PMID:20200208 FASLG Human nicotine increases expression ISO Faslg (Rattus norvegicus) 6480464 Nicotine results in increased expression of FASLG protein alternative form CTD PMID:18203686 FASLG Human nicotine increases expression EXP 6480464 Nicotine results in increased expression of FASLG mRNA and Nicotine results in increased expression of FASLG protein CTD PMID:18247414 more ... FASLG Human nicotine affects expression ISO Faslg (Rattus norvegicus) 6480464 Nicotine affects the expression of FASLG mRNA CTD PMID:20426880 FASLG Human nicotinic acid-adenine dinucleotide phosphate increases abundance ISO Fasl (Mus musculus) 6480464 FASL protein results in increased abundance of NAADP CTD PMID:20200208 FASLG Human nicotinic acid-adenine dinucleotide phosphate multiple interactions ISO Fasl (Mus musculus) 6480464 CD38 gene mutant form inhibits the reaction [FASL protein results in increased abundance of NAADP] more ... CTD PMID:20200208 FASLG Human nimustine increases expression EXP 6480464 Nimustine results in increased expression of FASLG mRNA CTD PMID:26418950 FASLG Human nimustine multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Nimustine results in increased expression of FASLG mRNA] CTD PMID:26418950 FASLG Human nitric oxide multiple interactions EXP 6480464 [linsidomine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter] more ... CTD PMID:10811113 FASLG Human nitrobenzene affects response to substance ISO Fasl (Mus musculus) 6480464 FASL protein affects the susceptibility to nitrobenzene CTD PMID:12595153 FASLG Human nocodazole multiple interactions EXP 6480464 [TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA and [TYMP co-treated with Nocodazole] results in decreased expression of FASLG protein CTD PMID:15907805 FASLG Human Nodularin increases expression EXP 6480464 nodularin results in increased expression of FASLG mRNA and nodularin results in increased expression of FASLG protein CTD PMID:21262250 FASLG Human Nodularin multiple interactions EXP 6480464 RELA mutant form inhibits the reaction [nodularin results in increased expression of FASLG mRNA] and RELA mutant form inhibits the reaction [nodularin results in increased expression of FASLG protein] CTD PMID:21262250 FASLG Human NS-398 multiple interactions EXP 6480464 [sodium arsenite co-treated with N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide] results in increased localization of and results in increased stability of FASLG protein CTD PMID:16487513 FASLG Human Nutlin-3 multiple interactions EXP 6480464 [nutlin 3 promotes the reaction [FAS protein binds to FASLG protein]] which results in increased susceptibility to Cisplatin and nutlin 3 promotes the reaction [FAS protein binds to FASLG protein] CTD PMID:21509038 FASLG Human ochratoxin A increases expression ISO Faslg (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of FASLG mRNA CTD PMID:19562491 FASLG Human octreotide increases expression EXP 6480464 Octreotide results in increased expression of FASLG protein CTD PMID:18642777 FASLG Human ouabain increases expression EXP 6480464 Ouabain results in increased expression of FASLG protein CTD PMID:31436044 FASLG Human ozone increases expression ISO Fasl (Mus musculus) 6480464 Ozone results in increased expression of FASL mRNA and Ozone results in increased expression of FASL protein CTD PMID:18315731 FASLG Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of FASLG mRNA CTD PMID:26760959 FASLG Human paclitaxel multiple interactions EXP 6480464 [esculetin co-treated with Paclitaxel] results in increased expression of FASLG protein more ... CTD PMID:15907805 and PMID:16051289 FASLG Human paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of FASLG mRNA and Paclitaxel results in increased expression of FASLG protein CTD PMID:10502406 more ... FASLG Human paclitaxel increases response to substance EXP 6480464 FASLG protein results in increased susceptibility to Paclitaxel CTD PMID:18074150 FASLG Human paracetamol increases expression ISO Fasl (Mus musculus) 6480464 Acetaminophen results in increased expression of FASL mRNA and Acetaminophen results in increased expression of FASL protein CTD PMID:12540782 more ... FASLG Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FASLG mRNA CTD PMID:27761495 FASLG Human paracetamol multiple interactions ISO Fasl (Mus musculus) 6480464 KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of FASL mRNA] more ... CTD PMID:12540782 more ... FASLG Human paracetamol increases response to substance ISO Fasl (Mus musculus) 6480464 FASL protein results in increased susceptibility to Acetaminophen CTD PMID:15578514 FASLG Human paraquat increases expression ISO Fasl (Mus musculus) 6480464 Paraquat results in increased expression of FASL mRNA CTD PMID:17215068 and PMID:9657385 FASLG Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of FASLG mRNA CTD PMID:18836921 FASLG Human parthenolide decreases expression EXP 6480464 parthenolide results in decreased expression of FASLG mRNA CTD PMID:16024633 FASLG Human pentobarbital decreases expression ISO Faslg (Rattus norvegicus) 6480464 Pentobarbital results in decreased expression of FASLG mRNA CTD PMID:16978161 FASLG Human pepstatin A multiple interactions ISO Faslg (Rattus norvegicus) 6480464 pepstatin inhibits the reaction [manganese chloride results in increased expression of FASLG protein] CTD PMID:28378122 FASLG Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of FASL mRNA CTD PMID:32790152 FASLG Human phenethyl caffeate multiple interactions ISO Fasl (Mus musculus) 6480464 caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased expression of FASL protein] CTD PMID:18436364 FASLG Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FASLG mRNA CTD PMID:19084549 FASLG Human phenol increases expression EXP 6480464 Phenol results in increased expression of FASLG protein CTD PMID:23776099 FASLG Human phenytoin multiple interactions ISO Fasl (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA and [Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of FASL mRNA CTD PMID:21224054 and PMID:23986454 FASLG Human phenytoin decreases expression ISO Fasl (Mus musculus) 6480464 Phenytoin results in decreased expression of FASL mRNA CTD PMID:23986454 FASLG Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA more ... CTD PMID:20529085 FASLG Human phylloquinone multiple interactions EXP 6480464 [Sorafenib co-treated with Vitamin K 1] results in increased expression of FASLG protein and pyrazolanthrone inhibits the reaction [[Sorafenib co-treated with Vitamin K 1] results in increased expression of FASLG protein] CTD PMID:20301194 FASLG Human platycodin D increases expression EXP 6480464 platycodin D results in increased expression of FASLG mRNA and platycodin D results in increased expression of FASLG protein CTD PMID:16631160 FASLG Human probenecid multiple interactions ISO Fasl (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:25406165 FASLG Human propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of FASLG mRNA CTD PMID:26079696 FASLG Human prostaglandin E2 increases expression ISO Fasl (Mus musculus) 6480464 Dinoprostone results in increased expression of FASLG CTD PMID:15491851 FASLG Human prostaglandin E2 multiple interactions ISO Fasl (Mus musculus) 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of FASL protein]] CTD PMID:25432964 FASLG Human prostaglandin E2 increases response to substance ISO Fasl (Mus musculus) 6480464 FASLG results in increased susceptibility to Dinoprostone CTD PMID:15491851 FASLG Human pterostilbene increases expression ISO Fasl (Mus musculus) 6480464 pterostilbene results in increased expression of FASL protein CTD PMID:20681671 FASLG Human puerarin multiple interactions EXP 6480464 arsenic trioxide promotes the reaction [puerarin results in increased expression of FASLG protein] CTD PMID:20416161 FASLG Human puerarin increases expression EXP 6480464 puerarin results in increased expression of FASLG protein CTD PMID:20416161 FASLG Human pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of FASLG mRNA CTD PMID:35321623 FASLG Human pyruvic acid multiple interactions EXP 6480464 Pyruvic Acid inhibits the reaction [FASL protein results in increased chemical synthesis of Hydrogen Peroxide] CTD PMID:17724027 FASLG Human quercetin decreases expression ISO Faslg (Rattus norvegicus) 6480464 Quercetin results in decreased expression of FASLG mRNA CTD PMID:10925121 FASLG Human quercetin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG mRNA] and Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of FASLG protein] CTD PMID:24316378 FASLG Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of FASLG mRNA and Quercetin results in increased expression of FASLG protein CTD PMID:21165570 more ... FASLG Human quercetin multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased expression of FASLG protein] more ... CTD PMID:21165570 and PMID:36982678 FASLG Human reactive oxygen species multiple interactions EXP 6480464 [Acetylcysteine results in decreased abundance of Reactive Oxygen Species] which results in decreased expression of FASLG mRNA more ... CTD PMID:22429591 FASLG Human reactive oxygen species increases expression EXP 6480464 Reactive Oxygen Species results in increased expression of FASLG mRNA CTD PMID:22429591 FASLG Human rebaudioside A increases expression EXP 6480464 rebaudioside A results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human regorafenib increases activity EXP 6480464 regorafenib results in increased activity of FASLG protein CTD PMID:30801954 FASLG Human resveratrol increases expression EXP 6480464 resveratrol analog results in increased expression of FASLG mRNA more ... CTD PMID:15217905 more ... FASLG Human resveratrol increases cleavage EXP 6480464 resveratrol results in increased cleavage of FASLG protein CTD PMID:22644961 FASLG Human resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of FASLG mRNA] more ... CTD PMID:17513867 more ... FASLG Human resveratrol increases expression ISO Fasl (Mus musculus) 6480464 resveratrol results in increased expression of FASL protein CTD PMID:17872969 FASLG Human rifampicin multiple interactions ISO Fasl (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FASL mRNA CTD PMID:21224054 FASLG Human rifampicin decreases expression EXP 6480464 Rifampin results in decreased expression of FASLG mRNA and Rifampin results in decreased expression of FASLG protein CTD PMID:11958592 and PMID:24552687 FASLG Human rifampicin multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein]] and Rifampin inhibits the reaction [FAS protein results in increased expression of FASLG protein] CTD PMID:12645856 FASLG Human ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of FASLG protein CTD PMID:10551732 FASLG Human Roridin A multiple interactions ISO Fasl (Mus musculus) 6480464 roridin A promotes the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of FASL mRNA] CTD PMID:17483119 FASLG Human ryanodine multiple interactions ISO Fasl (Mus musculus) 6480464 Ryanodine inhibits the reaction [FASL protein affects the localization of Calcium] CTD PMID:20200208 FASLG Human S-allylcysteine increases expression EXP 6480464 S-allylcysteine results in increased expression of FASLG protein CTD PMID:31067004 FASLG Human S-allylcysteine multiple interactions EXP 6480464 S-allylcysteine promotes the reaction [FAS protein binds to FASLG protein] and SB 203580 inhibits the reaction [S-allylcysteine promotes the reaction [FAS protein binds to FASLG protein]] CTD PMID:31067004 FASLG Human S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO Fasl (Mus musculus) 6480464 [Phenytoin co-treated with Buthionine Sulfoximine] results in decreased expression of FASL mRNA CTD PMID:23986454 FASLG Human S-nitroso-N-acetyl-D-penicillamine multiple interactions EXP 6480464 [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter] and [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] CTD PMID:10811113 FASLG Human S-nitrosoglutathione multiple interactions EXP 6480464 [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter] and [S-Nitrosoglutathione results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] CTD PMID:10811113 FASLG Human sanguinarine multiple interactions EXP 6480464 [sanguinarine co-treated with arsenic trioxide] results in increased expression of FASLG mRNA CTD PMID:24345465 FASLG Human SB 203580 multiple interactions EXP 6480464 SB 203580 affects the reaction [Temozolomide results in increased expression of FASLG mRNA] more ... CTD PMID:22644961 more ... FASLG Human SB 203580 multiple interactions ISO Fasl (Mus musculus) 6480464 SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of FASL mRNA] CTD PMID:16782274 FASLG Human Se-methyl-L-selenocysteine multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG CTD PMID:15897249 FASLG Human Se-methylselenocysteine multiple interactions EXP 6480464 [selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG CTD PMID:15897249 FASLG Human selenium atom multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA] CTD PMID:27920530 FASLG Human silicon dioxide increases expression ISO Fasl (Mus musculus) 6480464 Silicon Dioxide results in increased expression of FASL mRNA CTD PMID:29341224 FASLG Human sirolimus decreases secretion EXP 6480464 Sirolimus results in decreased secretion of FASLG protein CTD PMID:11692113 FASLG Human sodium arsenite affects activity EXP 6480464 sodium arsenite affects the activity of FASLG protein CTD PMID:18977016 FASLG Human sodium arsenite increases expression ISO Fasl (Mus musculus) 6480464 sodium arsenite results in increased expression of FASL protein CTD PMID:36000705 FASLG Human sodium arsenite increases expression ISO Faslg (Rattus norvegicus) 6480464 sodium arsenite results in increased expression of FASLG protein CTD PMID:20946910 FASLG Human sodium arsenite multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Atorvastatin co-treated with Acetylcysteine] inhibits the reaction [sodium arsenite results in increased expression of FASLG protein] CTD PMID:20946910 FASLG Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite co-treated with FASLG protein] results in increased cleavage of CASP3 protein more ... CTD PMID:16487513 and PMID:18977016 FASLG Human sodium dichromate decreases expression ISO Fasl (Mus musculus) 6480464 sodium bichromate results in decreased expression of FASL mRNA CTD PMID:31558096 FASLG Human sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of FASLG mRNA CTD PMID:19852076 FASLG Human sodium fluoride increases expression ISO Fasl (Mus musculus) 6480464 Sodium Fluoride results in increased expression of FASL mRNA CTD PMID:30130527 FASLG Human sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with Vitamin K 1] results in increased expression of FASLG protein and pyrazolanthrone inhibits the reaction [[sorafenib co-treated with Vitamin K 1] results in increased expression of FASLG protein] CTD PMID:20301194 FASLG Human steviol increases expression EXP 6480464 steviol results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human stevioside increases expression EXP 6480464 stevioside results in increased expression of FASLG mRNA CTD PMID:31655124 FASLG Human streptozocin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of FASLG protein] and rosiglitazone inhibits the reaction [Streptozocin results in increased expression of FASLG mRNA] CTD PMID:21791967 and PMID:28856781 FASLG Human streptozocin increases expression ISO Faslg (Rattus norvegicus) 6480464 Streptozocin results in increased expression of FASLG mRNA and Streptozocin results in increased expression of FASLG protein CTD PMID:21791967 and PMID:28856781 FASLG Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of FASLG protein CTD PMID:26833863 FASLG Human sumatriptan multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of FASLG protein] and Sumatriptan inhibits the reaction [Capsaicin results in increased expression of FASLG protein] CTD PMID:22150557 FASLG Human swainsonine increases expression ISO Faslg (Rattus norvegicus) 6480464 Swainsonine results in increased expression of FASLG protein CTD PMID:33186601 FASLG Human tacrolimus hydrate decreases secretion EXP 6480464 Tacrolimus results in decreased secretion of FASLG protein CTD PMID:11692113 FASLG Human tamoxifen multiple interactions ISO Faslg (Rattus norvegicus) 6480464 [BCL2 co-treated with Tamoxifen] results in increased expression of FASL protein and Tamoxifen inhibits the reaction [Estradiol results in increased expression of FASLG protein] CTD PMID:15545282 and PMID:15606891 FASLG Human tamoxifen increases expression EXP 6480464 [Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of FASLG mRNA and Tamoxifen results in increased expression of FASLG protein CTD PMID:12721755 and PMID:20145137 FASLG Human tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of FASLG mRNA CTD PMID:20145137 FASLG Human tamoxifen increases expression ISO Fasl (Mus musculus) 6480464 Tamoxifen results in increased expression of FASL protein CTD PMID:12721755 FASLG Human tamoxifen multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA] CTD PMID:20529085 FASLG Human telmisartan multiple interactions ISO Fasl (Mus musculus) 6480464 telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] CTD PMID:21620867 FASLG Human telmisartan multiple interactions ISO Faslg (Rattus norvegicus) 6480464 telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] CTD PMID:21819444 FASLG Human temozolomide multiple interactions EXP 6480464 pyrazolanthrone affects the reaction [temozolomide results in increased expression of FASLG mRNA] and SB 203580 affects the reaction [temozolomide results in increased expression of FASLG mRNA] CTD PMID:26418950 FASLG Human temozolomide increases expression EXP 6480464 temozolomide results in increased expression of FASLG mRNA CTD PMID:26418950 FASLG Human testosterone multiple interactions EXP 6480464 [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Testosterone] results in increased expression of FASLG mRNA and [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Testosterone] results in increased expression of FASLG protein CTD PMID:20529085 FASLG Human testosterone increases expression ISO Faslg (Rattus norvegicus) 6480464 Testosterone results in increased expression of FASLG mRNA CTD PMID:24658017 FASLG Human testosterone multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Testosterone results in increased expression of FASLG mRNA] more ... CTD PMID:12477725 and PMID:24658017 FASLG Human testosterone decreases expression ISO Faslg (Rattus norvegicus) 6480464 Testosterone deficiency results in decreased expression of FASLG protein CTD PMID:20850791 FASLG Human tetrachloromethane multiple interactions ISO Fasl (Mus musculus) 6480464 caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased expression of FASL protein] more ... CTD PMID:18291569 more ... FASLG Human tetrachloromethane increases expression ISO Fasl (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FASL mRNA and Carbon Tetrachloride results in increased expression of FASL protein CTD PMID:18291569 more ... FASLG Human tetrachloromethane increases expression ISO Faslg (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of FASLG mRNA and Carbon Tetrachloride results in increased expression of FASLG protein CTD PMID:16609999 more ... FASLG Human tetrachloromethane multiple interactions ISO Faslg (Rattus norvegicus) 6480464 IL10 protein promotes the reaction [Carbon Tetrachloride results in increased expression of FASLG mRNA] and IL10 protein promotes the reaction [Carbon Tetrachloride results in increased expression of FASLG protein] CTD PMID:16609999 and PMID:17105443 FASLG Human tetrazolium violet increases expression ISO Fasl (Mus musculus) 6480464 tetrazolium violet results in increased expression of FASL protein CTD PMID:18547555 FASLG Human thalidomide multiple interactions ISO Fasl (Mus musculus) 6480464 Thalidomide inhibits the reaction [SOD1 gene mutant form results in increased expression of FASL mRNA] CTD PMID:16510725 FASLG Human thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of FASLG protein CTD PMID:16531263 FASLG Human Theaflavin 3,3'-digallate affects expression EXP 6480464 theaflavin-3 and 3'-digallate affects the expression of FASLG mRNA CTD PMID:34925699 FASLG Human thioacetamide increases expression ISO Faslg (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of FASLG mRNA CTD PMID:34492290 FASLG Human thiosalicylic acid multiple interactions ISO Faslg (Rattus norvegicus) 6480464 thiosalicylic acid inhibits the reaction [Diethylnitrosamine results in decreased expression of FASL mRNA] CTD PMID:19427195 FASLG Human thymidine increases expression EXP 6480464 Thymidine results in increased expression of FASLG protein CTD PMID:16419169 FASLG Human Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of FASLG mRNA CTD PMID:21601586 FASLG Human trichloroethene increases methylation ISO Faslg (Rattus norvegicus) 6480464 Trichloroethylene results in increased methylation of FASLG gene CTD PMID:27618143 FASLG Human trichloroethene increases expression ISO Faslg (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of FASLG mRNA CTD PMID:33387578 FASLG Human trimethylarsine oxide increases expression ISO Faslg (Rattus norvegicus) 6480464 trimethylarsine oxide results in increased expression of FASLG mRNA CTD PMID:17481689 FASLG Human trimethyltin increases expression ISO Fasl (Mus musculus) 6480464 trimethyltin results in increased expression of FASL mRNA CTD PMID:24002884 FASLG Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of FASLG mRNA CTD PMID:37042841 FASLG Human Triptolide multiple interactions ISO Fasl (Mus musculus) 6480464 [triptolide co-treated with FASL protein] results in decreased expression of MIR137 more ... CTD PMID:24949944 and PMID:37944651 FASLG Human Triptolide increases expression ISO Fasl (Mus musculus) 6480464 triptolide results in increased expression of FASL mRNA and triptolide results in increased expression of FASL protein CTD PMID:24949944 and PMID:26990902 FASLG Human triptonide increases expression ISO Fasl (Mus musculus) 6480464 triptonide results in increased expression of FASL mRNA CTD PMID:33045310 FASLG Human troglitazone increases expression EXP 6480464 troglitazone results in increased expression of FASLG mRNA CTD PMID:19631733 FASLG Human Tungsten carbide multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of FASL mRNA CTD PMID:18078969 FASLG Human uranium atom increases expression ISO Faslg (Rattus norvegicus) 6480464 Uranium results in increased expression of FASLG mRNA CTD PMID:16854789 FASLG Human uridine increases expression EXP 6480464 Uridine results in increased expression of FASLG protein CTD PMID:16419169 FASLG Human usnic acid multiple interactions EXP 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FASLG mRNA CTD PMID:22777745 FASLG Human usnic acid decreases expression EXP 6480464 usnic acid results in decreased expression of FASLG mRNA CTD PMID:32508146 FASLG Human usnic acid increases expression EXP 6480464 usnic acid results in increased expression of FASLG mRNA CTD PMID:32508146 FASLG Human valsartan multiple interactions ISO Faslg (Rattus norvegicus) 6480464 benazepril promotes the reaction [Valsartan inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]] more ... CTD PMID:15315341 FASLG Human vanadyl sulfate decreases expression EXP 6480464 vanadyl sulfate results in decreased expression of FASLG protein CTD PMID:30407648 FASLG Human vanillin multiple interactions ISO Faslg (Rattus norvegicus) 6480464 vanillin inhibits the reaction [Cisplatin results in increased expression of FASLG protein] and vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein] CTD PMID:29216766 FASLG Human vemurafenib multiple interactions EXP 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of FASLG protein CTD PMID:27169980 FASLG Human vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of FASLG protein CTD PMID:11716366 FASLG Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of FASLG protein CTD PMID:11716366 FASLG Human vinorelbine multiple interactions ISO Fasl (Mus musculus) 6480464 [Cisplatin co-treated with vinorelbine] results in decreased expression of FASL mRNA CTD PMID:21544650 FASLG Human vorinostat multiple interactions EXP 6480464 [Bortezomib co-treated with Vorinostat] results in increased expression of FASLG mRNA more ... CTD PMID:17351739 FASLG Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of FASLG mRNA and vorinostat results in increased expression of FASLG protein CTD PMID:17351739 more ... FASLG Human wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [evodiamine results in increased expression of FASLG protein] CTD PMID:20005289 FASLG Human Y-27632 decreases expression EXP 6480464 Y 27632 results in decreased expression of FASLG mRNA CTD PMID:20878077 FASLG Human Y-27632 multiple interactions EXP 6480464 Y 27632 inhibits the reaction [Cisplatin results in increased expression of FASLG mRNA] CTD PMID:20878077 FASLG Human zearalenone increases expression ISO Faslg (Rattus norvegicus) 6480464 Zearalenone results in increased expression of FASLG mRNA and Zearalenone results in increased expression of FASLG protein CTD PMID:30600648 FASLG Human zidovudine increases expression ISO Fasl (Mus musculus) 6480464 Zidovudine results in increased expression of FASLG protein CTD PMID:17943461 FASLG Human zidovudine multiple interactions EXP 6480464 [Acrolein co-treated with Zidovudine] results in increased expression of FASLG protein more ... CTD PMID:27238871 FASLG Human zidovudine multiple interactions ISO Faslg (Rattus norvegicus) 6480464 Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA] more ... CTD PMID:27238871 FASLG Human zidovudine increases expression EXP 6480464 Zidovudine results in increased expression of FASLG mRNA CTD PMID:27238871 FASLG Human zidovudine increases expression ISO Faslg (Rattus norvegicus) 6480464 Zidovudine results in increased expression of FASLG mRNA CTD PMID:27238871 FASLG Human zinc atom increases expression EXP 6480464 Zinc results in increased expression of FASLG protein CTD PMID:16472982 FASLG Human zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of FASLG mRNA CTD PMID:22171008 FASLG Human zinc atom increases expression ISO Fasl (Mus musculus) 6480464 Zinc results in increased expression of FASLG mRNA and Zinc results in increased expression of FASLG protein CTD PMID:11864783 FASLG Human zinc atom multiple interactions ISO Fasl (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] CTD PMID:11864783 FASLG Human zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP3 protein] more ... CTD PMID:16051694 FASLG Human zinc(0) increases expression EXP 6480464 Zinc results in increased expression of FASLG protein CTD PMID:16472982 FASLG Human zinc(0) multiple interactions ISO Fasl (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Zinc results in increased expression of FASLG protein] CTD PMID:11864783 FASLG Human zinc(0) increases expression ISO Fasl (Mus musculus) 6480464 Zinc results in increased expression of FASLG mRNA and Zinc results in increased expression of FASLG protein CTD PMID:11864783 FASLG Human zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of FASLG mRNA CTD PMID:22171008 FASLG Human zoledronic acid affects expression EXP 6480464 zoledronic acid affects the expression of FASLG mRNA CTD PMID:19036117
